Atlas Trials

Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging

Clinical trial NCT01436604 · TERMINATED

Trial details

NCT number
NCT01436604
Sponsor
Centre Francois Baclesse
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer, BreastLV Dysfunction
Start date
2012-02-01
Primary completion
2015-08-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.